Dual role of the p75 tumor necrosis factor (tnf) receptor in tnf cytotoxicity

Journal of Experimental Medicine

Volumn 180, Issue 2, 1994, Pages 445-460

  Bigda, Jacek ^a,c   Beletsky, Igor ^a,d   Brakebusch, Cord ^a,e   Varfolomeev, Yevgeny ^a   Engelmann, Hartmut ^a,f   Bigda, Justina ^a   Holtmann, Helmut ^b   Wallach, David ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d LXR Biotechnology Inc   (United States)

^e Max Plack Institute ^*  (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CONFORMATIONAL TRANSITION; CROSS LINKING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HELA CELLS; HUMAN; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0028337454     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.2.445     Document Type: Article

References (65)

1. Hohmann, H.P., R. Remy, M. Brockhaus, and A.RG.M. van Loon. 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J. Biol. Chem. 264:14927.
2. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531.
3. Brockhaus, M., H. J. Schoenfeld, E. J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 87:3127.
4. Loetscher, H., Y.-C.E. Pan, H.-W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351.
5. Schall, T. J., M. Lewis, K. J. Roller, A. Lee, G.C. Rice, G.H.W. Wong, T. Gatanaga, G.A. Granger, R. Leutz, H. Raab, et al. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:361.
6. Nophar, Y., O. Kemper, C. Brakebusch, H. Englemann, R. Zwang, D. Aderka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:3269.
7. Smith, C.A., T. Davis, D. Anderson, L. Solam, M.P. Beckmann, R. Jerzy, S.K. Dower, D. Cosman, and R.G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (Wash. DC). 248:1019.
8. Heller, R.A., K. Song, M.A. Onasch, W.W. Fischer, and D. Change. 1990. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc. Natl. Acad. Sci. USA. 87:6151.
9. Olsson, I., M. Lantz, E. Nilsson, C. Peetre, H. Thysell, A. Grubb, and G. Adolf. 1989. Isolation and characterization of a tumor necrosis binding protein from urine. Eur. J. Haematol. 42:270.
10. Engelmann, H., D. Aderka, M. Rubinstein, D. Rotman, and D. Wallach. 1989. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem. 264:11974.
11. Seckinger, P., S. Isaaz, and J.M. Dayer. 1989. Purification and biologic characterization of a specific tumor necrosis factor a inhibitor. J. Biol. Chem. 264:11966.
12. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
13. Johnson, D., A. Lanahan, C.R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the NGF receptor. Cell. 47:545.
14. Stamenkovic, I., E.A. Clark, and B. Seed. 1989. A B-lympho-cyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO (Eur. Mol. Biol. Organ.) J. 8:1403.
15. Mallet, S., S. Fossum, and A.N. Barclay. 1990. Characterization of the MRC 0X40 antigen on activated CD40 positive T lymphocytes: a molecule related to nerve growth factor receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:1063.
16. Kwon, B.S., and S.M. Weissman. 1989. cDNA sequences of two inducible T-cell genes. Proc Natl. Acad. Sci. USA. 86:1963.
17. Camerini, D., G. Walz, W.A. Loenen, J. Borst, and B. Seed. 1991. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 143:3165.
18. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin’s disease. Cell. 68:421.
19. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233.
20. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, W.M. Li, S. Richards, J. Dhein, B.C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
21. Smith, C.A., T. Davis, J.M. Wignall, W.S. Din, T. Farrah, C. Upton, G. McFadden, and R.G. Goodwin. 1991. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biopbys. Res. Commutt. 176:335.
22. Armitage, R. J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, S.T. Davis, C.R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lortd.). 357:80.
23. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N. J. Chalupny, A.S. Braesch, R. J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO (Eur. Mot. Biol. Organ.) J. 11:4313.
24. Goodwin, R.G., M.R. Alderson, C.A. Smith, R. J. Armitage, B.T. Vanden, R. Jerzy, T.W. Tough, M.A. Schoenbom, S.T. Davis, K. Hennen, et al. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73:447.
25. Smith, C.A., FI. J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G.R. Sutherland, C.I. Brannan, N.G. Copeland, N.A. Jenkins, et al. 1993. CD30 antigen, a marker for Hodgkin’s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 73:1349.
26. Browning, J.L., E.A. Ngam, P. Lawton, MJ. De, R. Tizard, E.P. Chow, C. Hession, G.B. O’Brine, S.F. Foley, and C.F. Ware. 1993. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell. 72:847.
27. Suda, T., T. Takahashi, P. Goldstein, and N. Shigekazu. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169.
28. Banner, D.W., A. D’Arcy, W. Janes, R. Gentz, H. J. Schoen-feld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 73:431.
29. Brakebusch, C., Y. Nophar, O. Kemper, H. Engelmann, and D. Wallach. 1992. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 11:943.
30. Brakebusch, C., Y. Nophar, O. Kemper, D. Aderka, H. Engelmann, and D. Wallach. 1993. Diverse functions of the tumor necrosis factor receptors: structure-activity considerations. In Tumor Necrosis-Factor: Molecular and Cellular Biology and Clinical Relevance. Vol. 4. W. Fiers and W. A. Buurman, editors. S. Karger, Verlag, Basel, pp. 40-51.
31. Tartaglia, L.A., and D.V. Goeddel. 1992. Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J. Biol. Chem. 267:4304.
32. Tartaglia, L.A., T.M. Ayres, G.H. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:845.
33. Engelmann, H., H. Holtmann, C. Brakebusch, Y.S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
34. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415.
35. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M. J. Palladino, and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl. Acad. Sci. USA. 88:9292.
36. Kruppa, G., B. Thoma, T. Machleidt, K. Wiegmann, and M. Kronke. 1992. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol. 148:3152.
37. Vandenabeele, P., W. Declercq, D. Vercammen, M. Van de Craen, J. Grooten, H. Loetscher, M. Brockhaus, W. Lesslauer, and W. Fiers. 1992. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp Med. 176:1015.
38. Tartaglia, L.A., D. Pennica, and D.V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542.
39. Shalaby, M.R., A. Sundan, H. Loetscher, M. Brockhaus, W. Lesslauer, and T. Espevik. 1990. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp Med. 172:1517.
40. Hohmann, H.P., M. Brockhaus, P.A. Baeuerle, R. Remy, R. Kolbeck, and A.P.G.M. van Loon. 1990. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem. 265:22409.
41. Naume, B., R. Shalaby, W. Lesslauer, and T. Espevik. 1991. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146:3045.
42. Heller, R.A., K. Song, N. Fan, and D. J. Chang. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell. 70:47.
43. Gehr, G., R. Gentz, M. Brockhaus, H. Loetscher, and W. Lesslauer. 1992. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol. 149:911.
44. Grell, M., P. Scheurich, A. Meager, and K. Pfizenmaier. 1993. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res. 12:143.
45. Abe, Y., M. Gatanaga, Y. Osuka, S. Kimura, R.A. Burger, G.A. Granger, and T. Gatanaga. 1993. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J. Immunol. 150:5070.
46. Forni, L. 1979. Reagents for immunofluorescence and their use for studying lymphoid cell products. In Immunological Methods. I. Lefkovitz, and B. Pernis, editors. Academic Press, New York. 151-167.
47. Dembic, Z., H. Loetscher, U. Gubler, Y.C. Pan, H.W. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 2:231.
48. Gey, G.O., W.D. Coffman, and M.T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264.
49. Littlefield, J.W. 1964. Three degrees of guanylic acid-inosinic phosphorylase deficiency in mouse fibroblasts. Nature (Lond.). 203:1142.
50. Artelt, P., C. Morelle, M. Ausmeier, M. Fitzek, and H. Hauser. 1988. Vectors for efficient expression in mammalian fibro-blastoid, myeloid and lymphoid cells via transfection or infection. Gene (Amst.). 68:213.
51. Wallach, D. 1984. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol 132:2464.
52. Israel, S., T. Hahn, H. Holtmann, and D. Wallach. 1986. Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN. Immunol. Lett. 12:217.
53. Holtmann, H., and D. Wallach. 1987. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J. Immunol. 139:1161.
54. Studier, F.W., A.H. Rosenberg, J. J. Dunn, and J.W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
55. Holtmann, H., T. Hahn, and D. Wallach. 1988. Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. Immunobiology. 177:7.
56. Hahn, T., L. Toker, S. Budilovsky, D. Aderka, Z. Eshhar, and D. Wallach. 1985. Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. Proc Natl. Acad. Sci. USA. 82:3814.
57. Wong, G.H., J.H. Elwell, L.W. Oberley, and D.V. Goeddel. 1989. Manganeous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:923.
58. Kumar, S., and C. Baglioni. 1991. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960.
59. Opipari, A.W., H.M. Hu, R. Yabkowitz, and V.M. Dixit. 1992. The A20 Zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:12424.
60. Koenig, M., D. Wallach, K. Resch, and H. Holtmann. 1991. Induction of hyporesponsiveness to an early post-binding effect of tumor necrosis factor by tumor necrosis factor itself and interleukin 1. Eur. J. Immunol. 21:1741.
61. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (Wash. DC). 261:472.
62. Johnson, J.D., M.L. Wong, and W. J. Rutter. 1988. Properties of the insulin receptor ectodomain. Proc Natl. Acad. Sci. USA. 85:7516.
63. Greenfield, C., I. Hiles, M.D. Waterfield, M. Federwisch, A. Wollmer, T.L. Blundell, and N. McDonald. 1989. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO (Eur. Mol. Biol. Organ.) J. 8:4115.
64. Dransfield, I., C. Cabanas, J. Barrett, and N. Hogg. 1992. Interaction of leukocyte integrins with ligand is necessary but not sufficient for function. J. Cell Biol. 116:1527.
65. Thoma, B., M. Grell, K. Pfizenmaier, and P. Scheurich. 1990. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172:1019.